Press Release: Nextrove Successfully Hosts MedAssessment on AWS Cloud with Seamless Argus Migration
Nextrove Successfully Hosts MedAssessment on AWS Cloud with Seamless Argus Migration
January 2025
About Nextrove
Nextrove leads the industry in Pharmacovigilance Professional Services and Solutions. Our unwavering mission, “Empowering Clients to Improve Patient Safety,” propels us on the path to realizing our vision of becoming the first choice for Life Sciences professional services and solutions, in service of our clients, partners, and, above all, the patients we ultimately serve.
www.nextrove.com
info@nextrove.com
+1 347 551 1700
Nextrove LLC.
116 Village Boulevard,
Princeton Forrestal Village, Suite 208
Princeton, NJ 08540, USA
Nextrove LLC is proud to announce the successful migration and hosting of MedAssessment, a leading global CRO, onto the Nextrove AWS Cloud. This achievement showcases Nextrove’s commitment to delivering innovative, scalable solutions and exceptional service in the field of pharmacovigilance.
The President of MedAssessment Peg Fletcher, MD, PhD expressed her satisfaction with the project:
"This has been the smoothest migration I have experienced. The professionalism, dedication, and teamwork of the Nextrove team ensured the project’s success from start to finish. We couldn’t have asked for a better experience!"
The three-month project was a collaborative effort between MedAssessment and Nextrove’s dedicated team, including Abhisek, Abhinay, Rudra, Nivedita, Javid, Shalet, and Sumit, whose exceptional contributions kept the project on track.
MedAssessment also praised Nextrove’s proprietary migration methodology for its precision and efficiency, highlighting the seamless execution and the consistent support provided throughout the migration process.
MedAssessment, Inc. is a US-based Contract Research Organization (CRO) specializing in pharmacovigilance and early drug development assessments. They provide a comprehensive range of services including safety monitoring, signal detection, and medical writing to drug sponsors and clinical operations teams. With a dynamic team of multilingual medical professionals, MedAssessment leverages advanced technology to streamline safety data management and ensure compliant regulatory submissions. Their expertise is particularly focused on early-stage clinical trials, aiming to deliver high-quality safety profiles to facilitate faster product approvals.
Press Release: Nextrove expands in China
Nextrove expands in China with the launch of Nextrove China Ltd
January 2025, Shanghai
About Nextrove
Nextrove leads the industry in Pharmacovigilance Professional Services and Solutions. Our unwavering mission, “Empowering Clients to Improve Patient Safety,” propels us on the path to realizing our vision of becoming the first choice for Life Sciences professional services and solutions, in service of our clients, partners, and, above all, the patients we ultimately serve.
www.nextrove.com
info@nextrove.com
+1 347 551 1700
Nextrove LLC.
116 Village Boulevard,
Princeton Forrestal Village, Suite 208
Princeton, NJ 08540, USA
Nextrove China
2 / F, 2900 Nanxingang Road,
Fengxian District,
Shanghai
China
Nextrove LLC is proud to announce the establishment of its new subsidiary, Nextrove China Ltd, officially launched in November 2024.
With this new venture, Nextrove is thrilled to introduce two major offerings tailored for the Chinese market:
- NextCloud at AWS China
- Progressive Suite at Salesforce Alibaba
These solutions are designed to meet the growing demand for cloud-based services and automation in the pharmaceutical and clinical research industries.
Expertise in Pharmacovigilance and Technical Services
Nextrove China is committed to supporting local pharmaceutical companies, biotech firms, and Contract Research Organizations (CROs) with unparalleled expertise in pharmacovigilance (PV) and technical services. The local team, fluent in both Chinese and English, ensures seamless communication and collaboration with international partners.
Success Stories in Data Migration
Nextrove has already achieved notable successes in China, as demonstrated by two key case studies:
- End-to-End Data Migration for a CRO: Utilizing Nextrove’s proprietary system-agnostic migration tool, Progressive ClinConnect, the team facilitated a seamless migration from ArisG to Client Argus Cloud. This project also included implementing gateway connections with multiple countries, including China’s CDE.
- Data Migration for a Global Oncology Biotech Company: Nextrove completed a complex migration of case data to a local CRO. The data was split across two single-tenant databases, organized by study protocols, ensuring precision and compliance.
Goals for Nextrove in China
Nextrove aims to empower local pharmaceutical, biotech, and CRO organizations by enhancing their PV procedures through:
- Business transformation
- Automation solutions
- NextCloud hosting services
- Professional managed services
Join Us on WeChat
Nextrove China is also excited to announce the launch of its official WeChat site, providing PV-related news and insights entirely in Chinese. Follow us by scanning the QR code below or searching “Nextrove医焕安“ in the WeChat app.
Stay connected to learn more about our capabilities and offerings in the Chinese market!
About Our Leadership: Hsiao-Hui Hsu
Hsiao-Hui Hsu, General Manager and Vice President of Business Development at Nextrove China, brings over 29 years of experience in sales and marketing across industries such as pharmaceuticals, IT, and industrial automation. She holds a Bachelor’s degree in International Trade and a Master’s in Business Administration. Hsiao-Hui is focused on driving Nextrove’s growth in China.
Nextrove achieves ISO 27001 certification
About Nextrove
Nextrove leads the industry in Pharmacovigilance Professional Services and Solutions. Our unwavering mission, “Empowering Clients to Improve Patient Safety,” propels us on the path to realizing our vision of becoming the first choice for Life Sciences professional services and solutions, in service of our clients, partners, and, above all, the patients we ultimately serve.
www.nextrove.com
info@nextrove.com
+1 347 551 1700
Nextrove LLC.
116 Village Boulevard,
Princeton Forrestal Village, Suite 208
Princeton, NJ 08540, USA
Nextrove achieves ISO 27001 certification
November 2024, New Jersey
Nextrove is proud to share the achievement of ISO 27001 certification!
ISO 27001 is a globally recognized standard that ensures our systems, processes, and policies are designed to protect sensitive information and maintain the trust of our clients and partners.
This significant milestone reflects our commitment to the highest standards of information security management.
This underscores our unwavering commitment to information security and demonstrates our dedication to safeguarding our clients’ sensitive data.
By implementing robust security measures and maintaining the highest standards of operational excellence, Nextrove aims to build trust and confidence with every engagement.
Nextrove thanks each and everyone involved in this process and appreciates the talented team for their hard work and commitment in achieving this milestone.
We are excited to continue enhancing our services while prioritizing security and compliance.
Key Highlights:
- Robust Information Security Management: Our processes have been rigorously evaluated and improved to safeguard sensitive information.
- Continuous Improvement: This certification reinforces our dedication to ongoing risk management and operational excellence.
- Client Assurance: Clients can trust that their data is handled with the utmost care and in compliance with international standards.
Seamless Implementation of Next-Generation Life Sciences Software: Nextrove and ArisGlobal Announce Global Partnership
Drug Safety teams across the globe now have access to the latest solutions to gain efficiencies and optimize costs via a new strategic partnership between ArisGlobal and Nextrove.
Boston, Massachusetts, USA – February 22, 2024 – ArisGlobal, a leading innovative life sciences technology company and creator of LifeSphere®, has announced a new strategic partnership with Nextrove, an implementation, systems integration, and data migration specialist within life sciences. The partnership creates a larger pool of expert resources available to pharmaceutical organization implement next-generation LifeSphere solutions.
Customers across North America, Europe, United Kingdom (UK), India, China, South Korea, and Japan can leverage LifeSphere products via Nextrove implementation and expertise. The most recent client collaborations include KeyMed Biopharmaceuticals (China), and other pharmaceutical companies from the US, Europe, and Japan. Nextrove will help deliver ArisGlobal’s entire end-to-end LifeSphere Safety platform.
Together, ArisGlobal and Nextrove are able to deliver rapid and accelerated project implementations on-time and to-plan. The integrated team leverages proven, automated, and pre-developed tools with a highly standardized project lifecycle to execute projects with the highest quality and to-budget assurance.
Raj Hattarki, Senior Vice President, Head of Consulting at ArisGlobal, said:
“This partnership marks a significant step for ArisGlobal as it makes it even easier for life sciences organizations worldwide to adopt our sophisticated SaaS platform and modernize their Pharmacovigilance (PV) processes. As frontrunners in embracing state-of-the-art technologies like AI/ML in Drug Safety systems, teaming up with a partner like Nextrove is crucial. Nextrove brings complementary skills in modernizing PV operations and transitioning to advanced systems like LifeSphere Safety. This collaboration is set to speed up implementation process and ensure timely delivery, aligning with the high quality and service expectations our clients deserve.”
Anjani Jha, Chief Executive Officer of Nextrove, said:
“We are delighted at this opportunity to bring LifeSphere to pharma and biotech companies globally. This powerful platform is built on a completely new, cutting-edge technology architecture featuring the latest automation and cognitive computing technologies – something companies are crying out for more than ever. We’re excited at the prospect of streamlining companies’ access to these capabilities, whatever their current technology set-up.”
About ArisGlobal
ArisGlobal, the creator of LifeSphere, is a market leader in global patient treatment technology solutions that is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn. www.arisglobal.com. Media Contact Carina Birt, Sarum PR on behalf of ArisGlobal carina@sarumpr.com
About Nextrove
Nextrove, headquartered in New Jersey, USA, is a global professional services firm exclusively serving pharmaceutical and biotech organizations. Its professionals have extensive experience of performing complex integrations between PV, clinical, regulatory, and product quality databases. The company also provides a comprehensive range of tools and accelerators to aid data migrations and analysis of data issues, and fast-track new platform/solution implementations.